CC BY-NC-ND 4.0 · Endosc Int Open 2018; 06(04): E421-E424
DOI: 10.1055/s-0043-121986
Original article
Owner and Copyright © Georg Thieme Verlag KG 2018

Diagnostic adequacy and safety of endoscopic ultrasound-guided fine-needle aspiration in patients with lymphadenopathy in a large cohort

Rinkesh K. Bansal
1   Institute of Digestive and Hepatobiliary Sciences, Medanta The Medicity, Gurugram, India
,
Narendra S. Choudhary
1   Institute of Digestive and Hepatobiliary Sciences, Medanta The Medicity, Gurugram, India
,
Saurabh K. Patle
1   Institute of Digestive and Hepatobiliary Sciences, Medanta The Medicity, Gurugram, India
,
Mahesh K. Gupta
1   Institute of Digestive and Hepatobiliary Sciences, Medanta The Medicity, Gurugram, India
,
Chitranshu Vashishtha
1   Institute of Digestive and Hepatobiliary Sciences, Medanta The Medicity, Gurugram, India
,
Gagandeep Kaur
2   Department of Cytopathology, Medanta The Medicity, Gurugram, India
,
Haimanti Sarin
2   Department of Cytopathology, Medanta The Medicity, Gurugram, India
,
Rajesh Puri
1   Institute of Digestive and Hepatobiliary Sciences, Medanta The Medicity, Gurugram, India
› Author Affiliations
Further Information

Publication History

submitted 31 July 2017

accepted after revision 20 October 2017

Publication Date:
29 March 2018 (online)

Abstract

Background and study aims The role of endoscopic-ultrasound (EUS) guided fine-needle aspiration (FNA) in patients with lymphadenopathy in terms of diagnostic adequacy and safety in large population is not well defined. The aim of this study was to evaluate diagnostic adequacy and safety of EUS-FNA in patients with lymphadenopathy.

Patients and methods Retrospective study from October 2010 to September 2015 at tertiary care center in Delhi-NCR. We analyzed data from 1005 EUS- FNAs of lymph nodes.

Results The study cohort comprised 1005 lymph nodes in 865 patients; 68 % were males, mean age was 50 ± 14 years. Indications of FNA were to look for etiology of pyrexia of unknown origin or staging of malignancy mainly. FNA was taken from mediastinal nodes (n = 528, 52.5 %) and intra-abdominal nodes (n = 477, 47.5 %). Median size of nodes at long axis and short axis was 17 (12 – 25.7) and 10 (8 – 15) mm respectively. Adequate material by FNA was obtained in 92.8 % cases. The cytopathologic diagnosis were malignancy in 153 (15.2 %), granulomatous change in 452 (42 %), and reactive lymphadenopathy in 328 (35.6 %). There was statistically significant difference seen between groups with pathological and reactive lymph nodes regarding size at long and short axis, hypoechoic nature, well defined borders and presence of necrosis and calcification. Procedure-related adverse effects were encountered in 6 patients (0.8 %). Four patients had mild mucosal bleeding in chronic liver disease patients and two had mild hepatic encephalopathy related to sedation.

Conclusion EUS-FNA of lymph nodes has good diagnostic adequacy and safety.

 
  • References

  • 1 Catalano MF, Sivak Jr MV , Rice T. et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 1994; 40: 442-446
  • 2 Williams DB, Sahai AV, Aabakken L. et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 1999; 44: 720-726
  • 3 Chen VK, Eloubeidi MA. Endoscopic ultrasound-guided fine needle aspiration is superior to lymph node echo features: A prospective evaluation of mediastinal and peri-intestinal lymphadenopathy. Am J Gastroenterol 2004; 99: 628-633
  • 4 Nakahara O, Yamao K, Bhatia V. et al. Usefulness of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for undiagnosed intra-abdominal lymphadenopathy. J Gastroenterol 2009; 44: 562-567
  • 5 Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997; 45: 474-479
  • 6 Puli SR, Batapati KrishnaReddy J. et al. Endoscopic ultrasound: it's accuracy in evaluating mediastinal lymphadenopathy? A meta-analysis and systematic review. World journal of gastroenterology: WJG 2008; 14 (19) 3028-3037
  • 7 Chhieng DC, Jhala D, Jhala N. et al. Endoscopic ultrasound guided fine needle aspiration biopsy: A study of 103 cases. Cancer 2002; 96: 232-239
  • 8 Korenblit J, Anantharaman A, Loren DE. et al. The role of endoscopic ultrasound-guided fine needle aspiration (eus-fna) for the diagnosis of intra-abdominal lymphadenopathy of unknown origin. J Interv Gastroenterol 2012; 2: 172-176
  • 9 Catalano MF, Alcocer E, Chak A. et al. Evaluation of metastatic celiac axis lymph nodes in patients with esophageal carcinoma: accuracy of EUS. Gastrointest Endosc 1999; 50: 352-356
  • 10 Catalano MF, Nayar R, Gress F. et al. EUS guided fine needle aspiration in mediastinal lymphadenopathy of unknown etiology. Gastrointest Endosc 2002; 55: 863-911
  • 11 Yasuda I, Tsurumi H, Omar S. et al. Endoscopic ultrasound guided fine needle aspiration biopsy for lymphadenopathy of unknown origin. Endoscopy 2006; 38: 919-924
  • 12 Choudhary NS, Bansal RK, Puri R. et al. Impact of endoscopic ultrasound-guided fine needle aspiration of small lymph nodes. J Dig Endosc 2016; 7: 51-54